Gateway Investment Advisers LLC Has $960,000 Stock Holdings in Humana Inc. (NYSE:HUM)

Gateway Investment Advisers LLC increased its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 53.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,629 shares of the insurance provider's stock after acquiring an additional 1,263 shares during the period. Gateway Investment Advisers LLC's holdings in Humana were worth $960,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. FPC Investment Advisory Inc. bought a new stake in Humana during the fourth quarter worth $27,000. Centricity Wealth Management LLC bought a new position in shares of Humana in the 4th quarter valued at about $30,000. LFA Lugano Financial Advisors SA increased its stake in shares of Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares during the last quarter. Riverview Trust Co bought a new stake in shares of Humana in the 1st quarter valued at about $34,000. Finally, OFI Invest Asset Management bought a new stake in shares of Humana in the 4th quarter valued at about $33,000. Institutional investors own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

HUM has been the topic of several research analyst reports. Royal Bank of Canada restated an "outperform" rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Mizuho boosted their target price on Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 price target on shares of Humana in a research note on Thursday, May 1st. JPMorgan Chase & Co. cut their price target on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Finally, Oppenheimer upped their price objective on shares of Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a report on Thursday, May 1st. Sixteen research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $284.48.

Humana Price Performance

Shares of Humana stock traded up $2.34 during trading on Monday, reaching $233.04. 1,251,874 shares of the company's stock were exchanged, compared to its average volume of 1,787,502. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a 1-year low of $212.45 and a 1-year high of $406.46. The company has a market cap of $28.13 billion, a P/E ratio of 23.42, a PEG ratio of 2.05 and a beta of 0.43. The firm's 50-day moving average price is $253.49 and its 200 day moving average price is $264.69.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion for the quarter, compared to analysts' expectations of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. The business's revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $7.23 earnings per share. As a group, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.52%. Humana's payout ratio is presently 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.